January 31, 2017 Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients
February 28, 2017 Bring Your Own Device (BYOD) This webinar provides an overview of scientific, logistical, and regulatory considerations when using a BYOD approach to collect p
April 25, 2017 Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Event: Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Date: April 25, 2017 Location: Hyatt Rege
ReSeqTB Data Platform Now Available to Public January 17, 2017 TUCSON, Ariz., January 17, 2017 —The Rapid Drug Susceptibility Testing Consortium, coordinated by
December 1, 2017 Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
January 1, 2017 Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study
Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
January 12, 2016 Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments